EBRO 2017

Patients Selection

• Retrospective analysis of BC patients treated at the Institut Curie between 1981 and 1999.

• Genetic testing was proposed to women who presented one of the following family criteria:

– 2 first-degree relatives affected with cancer, with at least one with invasive BC before 41 yrs, or one with ovarian cancer at any age

– At least 3 first- or second-degree relatives from the same lineage affected with invasive breast or ovarian cancer at any age